Evidence map›Paper›PMID 35738151›Full record

ArticleJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology2022

A nationwide analytical and clinical evaluation of 44 rapid antigen tests for SARS-CoV-2 compared to RT-qPCR.

Uffe Vest Schneider, Maria Wendelboe Forsberg, Thomas Daell Leineweber, Christel Barker Jensen, Khaled Ghathian, Charlotte Nielsen Agergaard, Kasper Kjersgaard Mortensen, Arieh Cohen, Charlotte Sværke Jørgensen, Helene Larsen and 13 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 8 institutions in 1 country.

Uffe Vest SchneiderCopenhagen University Hospital Hvidovre, Department of Clinical Microbiology, Kettegaard Alle 30, 2650 Hvidovre, Denmark. Electronic address: uffe.vest.schneider@regionh.dk.
Maria Wendelboe ForsbergCopenhagen University Hospital Hvidovre, Department of Clinical Microbiology, Kettegaard Alle 30, 2650 Hvidovre, Denmark.
Thomas Daell LeineweberCopenhagen University Hospital Hvidovre, Department of Clinical Microbiology, Kettegaard Alle 30, 2650 Hvidovre, Denmark.
Christel Barker JensenCopenhagen University Hospital Hvidovre, Department of Clinical Microbiology, Kettegaard Alle 30, 2650 Hvidovre, Denmark.
Khaled GhathianCopenhagen University Hospital Hvidovre, Department of Clinical Microbiology, Kettegaard Alle 30, 2650 Hvidovre, Denmark.
Charlotte Nielsen AgergaardOdense University Hospital, Department of Clinical Microbiology, J. B. Winsløws Vej 21, 2., 5000 Odense C, Denmark.
Kasper Kjersgaard MortensenAarhus University Hospital, Department of Clinical Microbiology, Palle Juul-Jensens Boulevard 99, Skejby, 8200 Aarhus N., Denmark.
Arieh CohenDanish National Test Center, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen, Denmark.
Charlotte Sværke JørgensenStatens Serum Institut, Department of Virus & Microbiological Special Diagnostics, Artillerivej 5, 2300 Copenhagen, Denmark.
Helene LarsenTechnical University of Denmark - DTU, Centre for Diagnostics Department of Health Technology, Henrik Dams Allé, 2800 Kgs Lyngby, Denmark.
Matilde Bøgelund HansenCopenhagen University Hospital Herlev and Gentofte, Department of Clinical Microbiology, Borgmester Ib Juuls Vej 52, 2730 Herlev, Denmark.
Ulla SalemeCopenhagen University Hospital Bispebjerg and Frederiksberg, Department of Clinical Biochemistry, Nielsine Nielsens Vej 4B, 2400 Copenhagen, Denmark.
Anders KochRigshospitalet University Hospital, Department of Infectious Diseases, Blegdamsvej 9, 2100 Copenhagen, Denmark.
Nikolai Søren KirkbyRigshospitalet, Department of Clinical Microbiology, Henrik Harpestrengsvej 4A, 2100 Copenhagen, Denmark.
Thomas KallemoseCopenhagen University Hospital Hvidovre, Department of Clinical Research, Kettegaard Alle 30, 2650 Hvidovre, Denmark.
Marie Louise SchaadtCopenhagen University Hospital Hvidovre, Department of Clinical Microbiology, Kettegaard Alle 30, 2650 Hvidovre, Denmark.
Frederikke Holm JensenOdense University Hospital, Department of Clinical Microbiology, J. B. Winsløws Vej 21, 2., 5000 Odense C, Denmark.
Rikke Lind JørgensenCopenhagen University Hospital Hvidovre, Department of Clinical Microbiology, Kettegaard Alle 30, 2650 Hvidovre, Denmark.
Chih Man German MaCopenhagen University Hospital Hvidovre, Department of Clinical Microbiology, Kettegaard Alle 30, 2650 Hvidovre, Denmark.
Nina SteenhardDanish National Test Center, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen, Denmark.
Jenny Dahl KnudsenRigshospitalet, Department of Clinical Microbiology, Henrik Harpestrengsvej 4A, 2100 Copenhagen, Denmark.
Jan Gorm LisbyCopenhagen University Hospital Hvidovre, Department of Clinical Microbiology, Kettegaard Alle 30, 2650 Hvidovre, Denmark.
National Danish RAT testing groupThe Danish National rapid antigen testing group.
Copenhagen University Hospital · DKOdense University Hospital · DKHvidovre Hospital · DKRigshospitalet · DKStatens Serum Institut · DKAarhus University Hospital · DKGentofte Hospital · DKTechnical University of Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe SARS-CoV-2 pandemic has resulted in massive testing by Rapid Antigen Tests (RAT) without solid independent data regarding clinical performance being available. Thus, decision on purchase of a specific RAT may rely on manufacturer-provided data and limited peer-reviewed data.

methodsThis study consists of two parts. In the retrospective analytical part, 33 RAT from 25 manufacturers were compared to RT-PCR on 100 negative and 204 positive deep oropharyngeal cavity samples divided into four groups based on RT-PCR Cq levels. In the prospective clinical part, nearly 200 individuals positive for SARS-CoV-2 and nearly 200 individuals negative for SARS-CoV-2 by routine RT-PCR testing were retested within 72 h for each of 44 included RAT from 26 manufacturers applying RT-PCR as the reference method.

resultsThe overall analytical sensitivity differed significantly between the 33 included RAT; from 2.5% (95% CI 0.5-4.8) to 42% (95% CI 35-49). All RAT presented analytical specificities of 100%. Likewise, the overall clinical sensitivity varied significantly between the 44 included RAT; from 2.5% (95% CI 0.5-4.8) to 94% (95% CI 91-97). All RAT presented clinical specificities between 98 and 100%.

conclusionThe study presents analytical as well as clinical performance data for 44 commercially available RAT compared to the same RT-PCR test. The study enables identification of individual RAT that has significantly higher sensitivity than other included RAT and may aid decision makers in selecting between the included RAT.

fundingThe study was funded by a participant fee for each test and the Danish Regions.

Indexed as

COVID-19SARS-CoV-2Clinical Laboratory TechniquesCOVID-19 TestingHumansProspective StudiesRetrospective StudiesSensitivity and SpecificityAnalytical sensitivity and specificityClinical sensitivity and specificityPoint of care testsRapid antigen testsReverse transcriptation polymerase chain reactionSARS-CoV-2

Identifiers

PMID35738151
PMCPMC9173826
OpenAlexW4281749990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.